COMPANY PROFILE / #1490
Chemify
Glasgow, United KingdomVenture Capital-Backed
OVERVIEW
Developer of a chemical digitization platform intended to run chemical code for drug and materials discovery and chemical synthesis. The company's software involves a chemical programming language, natural language recognition for the translation of synthetic procedures, and a comprehensive ontology that allows for the straightforward creation of processes with insight into reaction conditions and flagging potential problems, enabling scientists to have detailed real-time reaction telemetry.
已融资120.65
最新估值145.73
员工数230
成立年份2019
公司概况
- Companies
- Chemify
- Description
- Developer of a chemical digitization platform intended to run chemical code for drug and materials discovery and chemical synthesis. The company's software involves a chemical programming language, natural language recognition for the translation of synthetic procedures, and a comprehensive ontology that allows for the straightforward creation of processes with insight into reaction conditions and flagging potential problems, enabling scientists to have detailed real-time reaction telemetry.
- Website
- www.chemify.io
- HQ Location
- Glasgow, United Kingdom
- Year Founded
- 2019
- Keywords
- chemical manufacture, chemicals synthesis, drug discovery, materials discovery, ontology development, synthetic drugs
- Competitors
- OpenEye Scientific Software, Conifer Point Pharmaceuticals, Numerate, Keen Eye, Cresset Biomolecular Discovery, VLife Sciences Technologies, Nanome, PathAI, Exscientia, Numerion Labs, insitro, Quark Pharmaceuticals, Pharmacelera, Cyclica
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 120.65
- First Financing Date
- 24-Oct-2019
- First Financing Size
- —
- First Financing Valuation
- —
- Last Financing Date
- 10-Dec-2025
- Last Financing Deal Type
- Grant
- Last Financing Size
- 3.20
- Last Financing Valuation
- —
- Last Financing Status
- Completed
- Last Known Valuation
- 145.73
- Last Known Valuation Date
- 21-Oct-2025
- Last Known Valuation Deal Type
- Later Stage VC
- Valuation Estimate
- 226.57
- Valuation Estimate Growth Rate
- 55.48%
- Active Investors
- 8VC, Alix Ventures, Ascent Ventures Group, Berggruen Holdings, BlueYard Capital, Caspian Capital, Creator Fund, David Cleevely, DCVC, Eos Advisory, Founders Fund, Gates Foundation, Government of UK, Hawktail, Horizons Ventures, Innovate UK, Insight Partners (New York), Lauder Partners, Meltwind Advisory, Paradigm Ventures (US), Possible Ventures, Rocketship.vc, Rockspring, Triatomic Capital, University of Glasgow, Wing Venture Capital, Zeon Ventures
- # Active Investors
- 27
- Acquirers
- —
团队与联系人
- Employees
- 230
- Employee Growth %
- 69.12%
- Employee History
- 2026: 230, 2025: 136, 2024: 79, 2023: 40, 2022: 15
- Primary Contact
- Leroy Cronin
- Primary Contact Title
- Co-Founder, Chief Executive Officer, CSO & Board Member
- Primary Contact Email
- lee@chemify.io
- Primary Contact Phone
- +44 (0)77 7332 1480
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- 0.93%
- Growth Rate % Change
- —
- Growth Rate Percentile
- 97
- Size Multiple
- 18.26x
- Size Multiple % Change
- 0.00%
- Size Multiple Change
- 0.00x
- Size Multiple Percentile
- 97
- Majestic Referring Domains
- 202
- SimilarWeb Unique Visitors
- 1,201
- SimilarWeb Unique Visitors Change
- 90
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- —
- Success Probability Over Time – 1 Year
- 31%
- Success Probability Over Time – 3 Year
- 51%
- Success Probability Over Time – 5 Year
- 62%
记录来源：public.companies · 原始序号 #1490 · 所有字段均按数据库原值展示。